Inogen (INGN) Depreciation & Amortization (CF) (2013 - 2026)
Inogen (INGN) reported Depreciation & Amortization (CF) of $4.9 million for Q1 2026, down 5.49% year-over-year from $5.2 million in Q1 2025, and down 2.6% quarter-over-quarter from $5.0 million in Q4 2025.
Inogen (INGN) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Depreciation & Amortization (CF) data on file, last reported at $4.9 million in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $4.9 million, down 5.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.4 million (down 2.65% YoY), and the FY2025 annual result was $20.7 million, down 1.64% from the prior year.
- Depreciation & Amortization (CF) retreated to $4.9 million in Q1 2026 per INGN's latest filing, from $5.0 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $6.0 million in Q4 2022 and troughed at $4.1 million in Q1 2023.
- A 5-year average of $5.2 million and a median of $5.2 million in 2025 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) dropped 29.06% in 2023, then gained 28.85% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $6.0 million in 2022, then dropped by 13.95% to $5.1 million in 2023, then declined by 1.24% to $5.1 million in 2024, then declined by 0.89% to $5.0 million in 2025, then slipped by 2.6% to $4.9 million in 2026.
- Business Quant data shows INGN's Depreciation & Amortization (CF) at $4.9 million in Q1 2026, $5.0 million in Q4 2025, and $5.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | 4.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.90 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 5.04 Mn |
| Dec 31, 2025 | 5.04 Mn |
| Sep 30, 2025 | 5.22 Mn |
| Sep 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | 5.22 Mn |
| Mar 31, 2025 | 5.19 Mn |
| Mar 31, 2025 | 5.19 Mn |
| Dec 31, 2024 | 5.08 Mn |
| Dec 31, 2024 | 5.08 Mn |
| Sep 30, 2024 | 5.31 Mn |
| Sep 30, 2024 | 5.31 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 5.27 Mn |
| Mar 31, 2024 | 5.27 Mn |
| Dec 31, 2023 | 5.14 Mn |
| Dec 31, 2023 | 5.14 Mn |